Peterson Ventures
2755 East Cottonwood Parkway Suite 400, Salt Lake City, UT, 84121, United States
Overview
Peterson Ventures is an early-stage venture capital firm focused on SaaS, digital commerce, and healthcare. They provide seed funding to entrepreneurs looking for a partner to help solve the challenges that accompany rapid growth.
- Total investments
- 60
- Lead investments
- 12
- Investments · 12mo
- 6
- Active investors
- 8
Sector focus
- Financial Services
- FinTech
- Venture Capital
Investment portfolio
- Tava Health
Participated · Series C · Apr 2026
Tava Health operates a technology-driven behavioral health platform that connects clinicians, employers, and health plans and offers tools across the care lifecycle. The company recently launched Symphony by Tava Health, an AI-assisted practice management system for clinicians; TavaCare for Employers, which can be fully sponsored or used with existing insurance without per-employee fees; and Tava Guide, a referral and care-tracking hub for payers and systems. Tava reports integrations with more than 200 health plans and claims in-network reach for nine in 10 commercially insured Americans, with first-session availability in as little as 12 hours. It also reports that 87% of its clients show measurable clinical improvement. The company says its platform is designed to reduce administrative burden for clinicians while removing cost barriers for employers. The new Series C funding will support deeper investment in partners and continued platform expansion.
- Two Boxes
Participated · Equity · Apr 2026
Two Boxes offers an AI-driven returns processing platform that uses image classification, anomaly detection, and fraud identification to modernize reverse logistics for retailers, direct-to-consumer brands, and logistics providers. The platform enables faster inventory recovery, reduced fraud-related losses, and improved operational efficiency, and currently processes nearly $1 billion in returned inventory value annually across three continents. Two Boxes has shown rapid 2025 growth, onboarding about two third-party logistics providers per month and one new merchant per day, and serves enterprise clients including Stord, Cart.com, and Radial. The company positions itself as foundational returns infrastructure amid rising returns volumes and returns-related fraud in e-commerce. With the new capital, Two Boxes plans to accelerate product development, expand enterprise adoption, and grow its presence beyond North America. No revenue or valuation figures were disclosed in the articles.
- Coral Care
Participated · Series A · Feb 2026
Founded in 2023 by Jen Wirt, Coral Care delivers pediatric speech, occupational, and physical therapy directly in children’s homes while equipping clinicians with software that handles credentialing, scheduling, billing, and documentation. The company operates in Massachusetts, New Hampshire, Texas, Illinois, and Pennsylvania, and has recently launched services in Dallas, Houston, Chicago, Philadelphia, and Pittsburgh. Coral Care’s network has grown to more than 400 licensed clinicians, and its platform reportedly cuts administrative workload by up to 15 hours per provider each week. More than 75% of families continue therapy for longer than four months, indicating strong engagement and retention. By embedding care in a child’s natural environment, the company aims to improve access, continuity, and contextual relevance of therapy. Coral Care plans to continue scaling its clinician base, enter additional markets, and further invest in its technology infrastructure using the newly raised capital. Its dual-sided model simultaneously increases provider supply and improves convenience for families seeking insurance-covered developmental care.
- Synthpop
Participated · Series A · Feb 2026
Founded in 2023 and headquartered in Cambridge, Massachusetts, Synthpop offers an API-first, multi-agent system that combines document intelligence, payer-aware reasoning, conversational voice agents, and an orchestration layer to streamline healthcare administration. The platform integrates directly with EHR, billing, and e-prescribe systems and can automate up to 80 % of business processes such as referrals, prior authorizations, eligibility checks, claims follow-ups, and other patient-access tasks. In production, Synthpop has already processed data for more than 2 million patients and connects with eight major EHR platforms. Customers report that workflows once taking 40 minutes are now completed in under a minute at a cost roughly five times lower than traditional human labor while maintaining full compliance. The company is SOC 2-audited and HIPAA-compliant, positioning it as a secure infrastructure provider within the healthcare ecosystem. With its latest funding, Synthpop plans to expand its team, deepen product capabilities, and move into additional healthcare verticals. Total funding to date stands at $23 million.
- Cambio
Participated · Series A · Jan 2026
Cambio’s cloud platform combines large language models with agentic AI workflows to read thousands of pages of utility bills, building assessments, and regulatory documents, turning months of manual analysis into minutes. The software flags retrofit opportunities, models cap-ex strategies, and delivers ROI-ranked recommendations, allowing landlords to decide where to deploy capital across large portfolios. In stealth, the company expanded to more than 35 countries, opened a London office, and signed marquee customers such as Principal Real Estate, Nuveen Real Estate, BGO, LaSalle Investment Management, Oxford Properties Group, Madison International Realty, and Beacon Capital Partners. Founded by alumni of KKR, Oxford Properties, JPMorgan, and Goldman Sachs while completing master’s degrees at Stanford, the team built Cambio after experiencing first-hand the inefficiencies of spreadsheet-driven asset management. The company has since added senior leaders who previously oversaw over $400 billion in global real-estate assets, underpinning its plan for rapid international scale. Cambio positions decarbonization and regulatory reporting not as compliance costs but as value-creation levers, reframing them into continuously learning decision engines. Although the company has not disclosed revenue or user counts, its early adoption across major institutional owners signals strong product-market fit in a $20 trillion industry.